UGA Biopharma’s core area of business is the contract development of biologics and
biosimilars. This involves all the necessary steps from cell line development
and bioprocess development to the development of purification and analysis
processes. UGA Biopharma’s unique selling feature is also that it offers its
customers what are known as ready-to-use biosimilar cell lines.
company supplies its customers in Germany and abroad from its headquarters in
Hennigsdorf and already has several users with UGA products in clinical trials
or who have already received market approval.
Biopharma GmbH was founded in Hennigsdorf (Germany) near Berlin in 2009. Since that time, our expertise has been constantly developing and expanding with an international team of now more than 40 permanent employees. A solid customer base ensures constant and solid growth.
Mission and Vision
UGA`s mission is to deliver high-end contract services that satisfy and exceed customer expectation. Good business practices and transparency in all aspects of client relationships are our core values and are essential for our philosophy and continued success. Our vision is to maintain UGA`s growth by supplying premium services and products to the cell culture community. With our dedication to constantly improve our operations, we see ourselves as a reputable and prosperous player known for quality and reliability.
Currently, we are implementing a quality management system that is based on the ICH Q10 regulation. This model assures products and services of appropriate quality are provided and delivered in compliance with regulations. To meet this commitment, UGA Biopharma encourages a quality-focused culture to ensure safe, efficient and reliable products and services for our customers and stakeholders. Each person at UGA Biopharma is made accountable for ensuring product and service quality.